George Farmer
Stock Analyst at Scotiabank
(2.17)
# 2,869
Out of 5,129 analysts
70
Total ratings
42.11%
Success rate
-0.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.31 | +663.36% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $69.84 | +90.44% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.57 | -61.78% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $21.14 | +122.33% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $21.71 | -21.70% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $6.48 | +85.19% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $2.33 | +286.27% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $13.12 | +212.50% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $34.24 | +51.87% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $60.31 | +32.65% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $191.20 | +17.15% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $28.55 | +257.27% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $7.84 | +27.55% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $834.55 | -14.33% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.63 | +308.53% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.73 | +2,658.62% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $18.54 | +309.92% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.60 | +400.00% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $40.51 | +169.07% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $98.84 | -11.98% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.83 | +1,703.28% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.74 | +5,288.66% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $42.94 | -37.12% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.31
Upside: +663.36%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $69.84
Upside: +90.44%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.57
Upside: -61.78%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $21.14
Upside: +122.33%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $21.71
Upside: -21.70%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $6.48
Upside: +85.19%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $2.33
Upside: +286.27%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $13.12
Upside: +212.50%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $34.24
Upside: +51.87%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $60.31
Upside: +32.65%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $191.20
Upside: +17.15%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $28.55
Upside: +257.27%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $7.84
Upside: +27.55%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $834.55
Upside: -14.33%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.63
Upside: +308.53%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.73
Upside: +2,658.62%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $18.54
Upside: +309.92%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.60
Upside: +400.00%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $40.51
Upside: +169.07%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $98.84
Upside: -11.98%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.83
Upside: +1,703.28%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.74
Upside: +5,288.66%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $42.94
Upside: -37.12%